Health Canada NHP Labelling: 2026 Interchangeable Terms Explained

Health Canada has updated its List of Interchangeable Terms for Natural Health Products (NHPs), giving manufacturers greater flexibility in certain labelling and claims. The August 20, 2026 update expands the use of interchangeable terminology and clarifies that the list is not exhaustive for NHPs and applicable List D non-prescription drugs (NPDs). For NHP manufacturers, importers,… Continue reading Health Canada NHP Labelling: 2026 Interchangeable Terms Explained

MoCRA Serious Adverse Event Reporting: A Complete Compliance Guide for Cosmetic Brands Selling in the United States

A single customer complaint can become a regulatory issue much faster than many cosmetic brands realize. Under the Modernization of Cosmetics Regulation Act (MoCRA), companies marketing cosmetic products in the United States must carefully evaluate complaints and determine whether they qualify as serious adverse events requiring FDA reporting. For cosmetic manufacturers, private label brands, importers,… Continue reading MoCRA Serious Adverse Event Reporting: A Complete Compliance Guide for Cosmetic Brands Selling in the United States